DE69415319T2 - Verfahren zur herstellung von piperidinderivaten - Google Patents

Verfahren zur herstellung von piperidinderivaten

Info

Publication number
DE69415319T2
DE69415319T2 DE69415319T DE69415319T DE69415319T2 DE 69415319 T2 DE69415319 T2 DE 69415319T2 DE 69415319 T DE69415319 T DE 69415319T DE 69415319 T DE69415319 T DE 69415319T DE 69415319 T2 DE69415319 T2 DE 69415319T2
Authority
DE
Germany
Prior art keywords
production
alkyl
compounds
piperide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69415319T
Other languages
English (en)
Other versions
DE69415319D1 (de
Inventor
Ambra Thomas D
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AMR Technology Inc
Original Assignee
Albany Molecular Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22176189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69415319(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Albany Molecular Research Inc filed Critical Albany Molecular Research Inc
Application granted granted Critical
Publication of DE69415319D1 publication Critical patent/DE69415319D1/de
Publication of DE69415319T2 publication Critical patent/DE69415319T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/86Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69415319T 1993-06-24 1994-06-21 Verfahren zur herstellung von piperidinderivaten Expired - Lifetime DE69415319T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8310293A 1993-06-24 1993-06-24
PCT/US1994/006873 WO1995000482A1 (en) 1993-06-24 1994-06-21 Piperidine derivatives and process for their production

Publications (2)

Publication Number Publication Date
DE69415319D1 DE69415319D1 (de) 1999-01-28
DE69415319T2 true DE69415319T2 (de) 1999-06-10

Family

ID=22176189

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69433346T Expired - Lifetime DE69433346T2 (de) 1993-06-24 1994-06-21 Herstellung von Verbindungen, die in der Produktion von Piperidin-Derivaten nützlich sind
DE69434696T Expired - Lifetime DE69434696T2 (de) 1993-06-24 1994-06-21 Verfahren zur Herstellung von Verbindungen geeignet als Zwischenprodukte
DE69415319T Expired - Lifetime DE69415319T2 (de) 1993-06-24 1994-06-21 Verfahren zur herstellung von piperidinderivaten

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE69433346T Expired - Lifetime DE69433346T2 (de) 1993-06-24 1994-06-21 Herstellung von Verbindungen, die in der Produktion von Piperidin-Derivaten nützlich sind
DE69434696T Expired - Lifetime DE69434696T2 (de) 1993-06-24 1994-06-21 Verfahren zur Herstellung von Verbindungen geeignet als Zwischenprodukte

Country Status (16)

Country Link
US (9) US5589487A (de)
EP (4) EP0703902B1 (de)
JP (4) JP3034047B2 (de)
KR (2) KR100387347B1 (de)
AT (3) ATE174589T1 (de)
AU (1) AU670004B2 (de)
CA (1) CA2147126C (de)
DE (3) DE69433346T2 (de)
DK (3) DK1369409T3 (de)
ES (3) ES2211444T3 (de)
FI (1) FI109691B (de)
HU (1) HU226559B1 (de)
NO (2) NO308599B1 (de)
NZ (1) NZ268513A (de)
PT (2) PT1369409E (de)
WO (1) WO1995000482A1 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2284351B (en) * 1992-08-03 1996-11-27 Sepracor Inc Terfenadine metabolites and their optically pure isomers for treating allergic disorders
EP0703902B1 (de) 1993-06-24 1998-12-16 Albany Molecular Research, Inc. Verfahren zur herstellung von piperidinderivaten
US20020007068A1 (en) 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
CA2362337C (en) 1993-06-25 2005-08-02 Merrell Pharmaceuticals Inc. Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
CA2585705C (en) 1994-05-18 2012-04-17 Aventis Pharmaceuticals Inc. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
PT812195E (pt) 1995-02-28 2003-03-31 Aventis Pharma Inc Composicao farmaceutica para compostos de piperidinoalcanol
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US5925761A (en) * 1997-02-04 1999-07-20 Sepracor Inc. Synthesis of terfenadine and derivatives
ZA985939B (en) 1997-07-08 2000-01-10 Aristocrat Leisure Ind Pty Ltd Slot machine game and system with improved jackpot feature.
AU725811B2 (en) * 1997-08-26 2000-10-19 Aventisub Llc Pharmaceutical composition for combination of piperidinoalkanol-decongestant
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6930197B2 (en) 1998-07-02 2005-08-16 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6683094B2 (en) 1998-07-02 2004-01-27 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
DK1091938T3 (da) * 1998-07-02 2011-02-07 Aventisub Ii Inc Antihistamin piperidinderivativer og mellemprodukter til fremstilling af disse
AU2007200674C1 (en) * 1998-07-02 2011-02-24 Aventisub Llc Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6362375B1 (en) 1999-12-03 2002-03-26 College Of The Holy Cross Process for the preparation of aryl ketones generating reduced amounts of toxic byproducts
US6613906B1 (en) 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
GB0018691D0 (en) * 2000-07-28 2000-09-20 Rolabo Sl Process
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
MXPA03009259A (es) * 2001-04-09 2004-06-03 Teva Pharma Polimorfos de clorhidrato de fexofenadina.
US6743941B2 (en) 2001-06-15 2004-06-01 Aventis Pharma Deutschland Gmbh Process for the production of piperidine derivatives
SK712003A3 (en) * 2001-06-25 2003-12-02 Aurobindo Pharma Ltd Process for the preparation of 4-(cyclopropylcarbonyl)-alpha, alpha-dimethylphenylacetic acid
US6593499B2 (en) * 2001-08-29 2003-07-15 Council Of Scientific & Industrial Research Process for the preparation of phenyl ketones
WO2003039482A2 (en) * 2001-11-08 2003-05-15 Teva Pharmaceutical Industries Ltd. Polymorphs of fexofenadine base
KR20040088519A (ko) 2002-02-22 2004-10-16 뉴 리버 파마슈티칼스, 인크. 활성 제제 전달 시스템 및 활성 제제의 보호 및 투여 방법
JP2005532356A (ja) * 2002-06-10 2005-10-27 テバ ファーマシューティカル インダストリーズ リミティド 塩酸フェキソフェナジンの多型体xvi
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
CA2560882A1 (en) * 2004-04-26 2005-11-03 Teva Pharmaceutical Industries Ltd. Crystalline forms of fexofenadine hydrochloride and processes for their preparation
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
WO2006037042A1 (en) * 2004-09-28 2006-04-06 Teva Pharmaceutical Industries Ltd. Fexofenadine crystal form and processes for its preparation thereof
US7841939B2 (en) 2005-09-09 2010-11-30 Igt Server based gaming system having multiple progressive awards
KR20080065704A (ko) 2005-11-09 2008-07-14 콤비네이토릭스, 인코포레이티드 의학적 이상의 치료 방법들, 조성물들, 및 키트들
US7780520B2 (en) 2006-03-15 2010-08-24 Igt Gaming device having multiple different types of progressive awards
WO2007135693A2 (en) * 2006-05-18 2007-11-29 Ind-Swift Laboratories Limited Intermediates useful for the preparation of antihistaminic piperidine derivative
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
US8070597B2 (en) 2006-08-03 2011-12-06 Igt Gaming device and method having multiple progressive award levels and a secondary game for advancing through the progressive award levels
US9047733B2 (en) 2006-11-08 2015-06-02 Igt Gaming system and method for providing multiple level progressive awards with increased odds of winning higher level progressive awards
EP2105134A1 (de) 2008-03-24 2009-09-30 Ranbaxy Laboratories Limited Stabiles und amorphes Fexofenadin-Hydrochlorid
WO2009136412A2 (en) * 2008-04-25 2009-11-12 Matrix Laboratories Limited PROCESS FOR PREPARATION OF 4-[4-(4-(HYDROXYDIPHENYLMETHYL)- 1-PIPERIDINYL]-1-OXOBUTYL]-α,α-DIMETHYLBENZENE ACETIC ACID METHYL ESTER AND USE THEREOF
US8318705B2 (en) 2008-05-07 2012-11-27 Cardioxyl Pharmaceuticals, Inc. Nitroso compounds as nitroxyl donors and methods of use thereof
US20090306025A1 (en) * 2008-05-30 2009-12-10 Fairfield Clinical Trials, Llc Method and composition for skin inflammation and discoloration
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
EP2289867A3 (de) 2009-08-19 2012-04-25 Jubilant Organosys Limited Verfahren zur Herstellung von 4-(4-Halogen-1-oxybutyl)-alpha,alpha-dimethylbenzolessigsäure oder Alkylestern davon
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
CN102070512B (zh) * 2009-11-21 2014-11-19 浙江华海药业股份有限公司 一种高纯度非索非那定及其中间体的合成路线与制备方法
WO2011063339A1 (en) * 2009-11-23 2011-05-26 Cardioxyl Pharmaceuticals, Inc. Nitroxyl donors for the treatment of pulmonary hypertension
CN102962288A (zh) * 2012-11-21 2013-03-13 苏州江南航天机电工业有限公司 圆弧状大板与直板拼接工艺
ITMI20131652A1 (it) 2013-10-07 2015-04-08 Dipharma Francis Srl Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
PT3365327T (pt) * 2015-10-22 2020-02-06 Sanofi Aventis Deutschland Processo para a preparação de fexofenadina e de intermediários usados no mesmo

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028404A (en) * 1967-07-31 1977-06-07 Allen & Hanburys Limited Acetic acid derivatives
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives
US3839431A (en) * 1970-07-13 1974-10-01 Squibb & Sons Inc Cyclopropylmethylphenylacetic acids and derivatives
US3898271A (en) * 1971-06-08 1975-08-05 Squibb & Sons Inc Cyclopropylmethylphenylacetic acids and derivatives
BE794598A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
BE794596A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Piperidinoalcanone-oximes substituees et leur procede de preparation
US3965257A (en) * 1972-01-28 1976-06-22 Richardson-Merrell Inc. Compositions and methods for the treatment of the symptoms of histamine induced allergic reactions
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3941795A (en) * 1974-02-08 1976-03-02 Richardson-Merrell Inc. α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
US3931197A (en) * 1974-02-08 1976-01-06 Richardson-Merrell Inc. Substituted piperidine derivatives
US3946022A (en) * 1974-03-04 1976-03-23 Richardson-Merrell Inc. Piperidine derivatives
US3922276A (en) * 1974-12-11 1975-11-25 Robins Co Inc A H 1-Substituted-4-benzylidenepiperidines
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
DD141422A5 (de) * 1978-01-27 1980-04-30 Schering Ag Verfahren zur herstellung von phenylessigsaeure-derivaten
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
GB8321157D0 (en) * 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
IT1200123B (it) 1985-09-27 1989-01-05 Ind Chimica Srl Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
EP0635004B1 (de) * 1992-04-10 2002-07-17 Merrell Pharmaceuticals Inc. 4-diphenylmethylpiperidine und verfahren zu ihrer herstellung
GB2284351B (en) * 1992-08-03 1996-11-27 Sepracor Inc Terfenadine metabolites and their optically pure isomers for treating allergic disorders
EP0703902B1 (de) * 1993-06-24 1998-12-16 Albany Molecular Research, Inc. Verfahren zur herstellung von piperidinderivaten
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
US6147216A (en) 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
CA2362337C (en) * 1993-06-25 2005-08-02 Merrell Pharmaceuticals Inc. Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
US7022882B2 (en) * 2000-10-06 2006-04-04 The Regents Of The University Of California NMDA receptor channel blocker with neuroprotective activity

Also Published As

Publication number Publication date
NO994582D0 (no) 1999-09-21
HU226559B1 (en) 2009-03-30
KR960703398A (ko) 1996-08-17
NZ268513A (en) 1996-09-25
NO994582L (no) 1995-12-12
ATE322473T1 (de) 2006-04-15
US5750703A (en) 1998-05-12
ES2261871T3 (es) 2006-11-16
DK1026147T3 (da) 2004-03-22
DE69433346T2 (de) 2004-09-09
EP1026147B1 (de) 2003-11-19
AU7174894A (en) 1995-01-17
FI956270A0 (fi) 1995-12-27
KR100387348B1 (ko) 2003-06-12
JPH11236373A (ja) 1999-08-31
WO1995000482A1 (en) 1995-01-05
AU670004B2 (en) 1996-06-27
JP4124998B2 (ja) 2008-07-23
US20060052610A1 (en) 2006-03-09
JPH08511806A (ja) 1996-12-10
EP1369409B1 (de) 2006-04-05
DE69434696D1 (de) 2006-05-18
JP3658291B2 (ja) 2005-06-08
US20060241303A1 (en) 2006-10-26
DE69415319D1 (de) 1999-01-28
KR100387347B1 (ko) 2003-11-28
US7390906B2 (en) 2008-06-24
DE69434696T2 (de) 2006-11-16
PT1369409E (pt) 2006-08-31
JP3034047B2 (ja) 2000-04-17
JP2001031650A (ja) 2001-02-06
HU9503719D0 (en) 1996-02-28
ES2211444T3 (es) 2004-07-16
ATE174589T1 (de) 1999-01-15
US5589487A (en) 1996-12-31
US5578610A (en) 1996-11-26
PT1026147E (pt) 2004-04-30
EP0723958A1 (de) 1996-07-31
DK0703902T3 (da) 1999-08-23
EP1026147A1 (de) 2000-08-09
US5581011A (en) 1996-12-03
HUT73235A (en) 1996-07-29
DE69433346D1 (de) 2003-12-24
EP1369409A1 (de) 2003-12-10
EP0703902B1 (de) 1998-12-16
EP0703902A4 (de) 1996-04-10
DK1369409T3 (da) 2006-08-14
US7238834B2 (en) 2007-07-03
ES2129130T3 (es) 1999-06-01
US5994549A (en) 1999-11-30
JP3195297B2 (ja) 2001-08-06
NO955023L (no) 1995-12-12
NO308599B1 (no) 2000-10-02
US5663412A (en) 1997-09-02
FI956270A (fi) 1995-12-27
ATE254594T1 (de) 2003-12-15
EP0703902A1 (de) 1996-04-03
NO955023D0 (no) 1995-12-12
JP2002212166A (ja) 2002-07-31
FI109691B (fi) 2002-09-30
US20080227983A1 (en) 2008-09-18
CA2147126C (en) 1999-08-24
CA2147126A1 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
DE69415319D1 (de) Verfahren zur herstellung von piperidinderivaten
ATE282020T1 (de) Verfahren zur herstellung von 2-aminomalonsäure- derivaten
ATE335726T1 (de) Verfahren zur herstellung von piperidinderivaten
ATE158568T1 (de) Verfahren zur herstellung von quaternären diestern
DE69719781D1 (de) Zwischenprodukte zur Herstellung von Duocarmycin SA und dessen Derivaten sowie ein Verfahren zur Herstellung der Zwischenprodukte
ATE202087T1 (de) Verfahren zur herstellung von 4-substituierten azetidinon-derivaten
DE69231815T2 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
ATE519747T1 (de) Verfahren zur herstellung von cyclopentaägüchinazolin-derivaten
DE69106003D1 (de) Verfahren und zwischenprodukte zur herstellung von azabicyclo[2.2.2]octan-3-iminen.
ATE201201T1 (de) Verfahren zur herstellung von pyrimidinderivaten
ATE383353T1 (de) Verfahren zur herstellung von 2-alkyl-3- aminothiophen derivate und 3-aminothiophen derivate
DE69311500D1 (de) 2,3-Diphenyl-5-pyrrolyl-furan Derivate, Verfahren und Zwischenprodukte für ihre Herstellung und ihre Verwendung als entzündungshemmende, antiallergische und blutplättchenaggregationshemmende Mittel
DE69405439T2 (de) Verfahren zur Herstellung von Aminotriazin-Derivaten
ATE299498T1 (de) Verfahren zur herstellung von imidazolderivaten
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
DE3772703D1 (de) Verfahren zur herstellung von penemen.
ATE329917T1 (de) 1h-pyrrolo 1,2-bö 1,2,4ötriazolederivate, zwischenprodukte und verfahren zur herstellung von 1h-1,2,4,-triazol-5-yl essigsäureesterderivate
ATE57934T1 (de) Verfahren zur herstellung von griseolinsaeurederivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee
8327 Change in the person/name/address of the patent owner

Owner name: AMR TECHNOLOGY,INC., MANCHESTER CENTER, VT., US

8370 Indication related to discontinuation of the patent is to be deleted
R082 Change of representative

Ref document number: 703902

Country of ref document: EP

Representative=s name: ANWALTSKANZLEI GULDE HENGELHAUPT ZIEBIG & SCHNEIDE